23andMe Holding Co. (ME) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

23andMe Holding Co. (ME)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.38

-0.26 (-7.14%)

At close: Jan 14, 2025, 3:59 PM

undefined% (undefined)

Bid	3.19
Market Cap	92.39M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-116.14
PE Ratio (ttm)	-0.03
Forward PE	n/a
Analyst	Hold

Ask	3.98
Volume	179,780
Avg. Volume (20D)	344,286
Open	3.70
Previous Close	3.64
Day's Range	3.37 - 3.79
52-Week Range	2.65 - 16.52
Beta	undefined

About ME

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact respo...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Nov 23, 2020

Employees 560

Stock Exchange NASDAQ

Ticker Symbol ME

Website https://www.23andme.com

Analyst Forecast

According to 1 analyst ratings, the average rating for ME stock is "Hold." The 12-month stock price forecast is $9.4, which is an increase of 178.11% from the latest price.

Buy 0.00%

Hold 100.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

23andMe Holding Co. is scheduled to release its earnings on Feb 5, 2025, during market hours.
Analysts project revenue of $54.30M, reflecting a 21.35% YoY growth and earnings per share of -0.16, making a -95.00% decrease YoY.

Why Price Moved

2 months ago · Source

-21.47%

23andMe shares are trading lower. The stock may be... Unlock content with Pro Subscription

3 months ago · Source

-2.67%

23andMe shares are trading lower. The company announced a 1-for-20 reverse stock split, effective October 16.

News

1 month ago · newsfilecorp.com

Metals Creek Resources Corp. Closes First Tranche of Flow-Through Private Placement Financing - Secures Drill for Next Phase of Tillex Copper Project Drilling

Thunder Bay, Ontario--(Newsfile Corp. - November 18, 2024) - Metals Creek Resources Corp. (TSXV: ME) (FSE: M1C1) (the "Company" or Metals Creek) further to its November 5, 2024 news release, the Compa...

2 months ago · seekingalpha.com

23andMe Holding Co. (ME) Q2 2025 Earnings Call Transcript

23andMe Holding Co. (NASDAQ:ME ) Q2 2025 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Katie Watson - Vice President, Communications Anne Wojcicki - Chief Executive Office...

2 months ago · techcrunch.com

23andMe cuts 40% of staff in restructuring

23andMe announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at the company. The genetic testing company is also discontinuing its th...

2 months ago · fastcompany.com

What's happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled DNA testing company

DNA-testing company 23andMe (Nasdaq: ME), once an industry leader that attracted millions of customers, including rapper Snoop Dogg and investor Warren Buffett, has announced significant cuts to its o...

2 months ago · cnbc.com

23andMe reports sales decline day after announcing plans to cut 40% of workforce

23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The embattled genetic testing company said Monday that it's cutting about 200 jobs, or ab...

2 months ago · marketwatch.com

23andMe's stock turns lower after company posts its latest quarterly loss

Stock had gained late Monday on news it would cut 40% of its workforce as part of a restructuring.

2 months ago · proactiveinvestors.co.uk

23andMe to cut 40% of its workforce as it looks to stablise the business

Genetic testing firm 23andMe announced plans to cut 40% of its workforce, or around 200 jobs, as part of a cost-saving effort aimed at stabilising the company. It will also halt work on its therapy de...

2 months ago · wsj.com

23andMe Lays Off 40% of Staff, Shuts Drug Development Business

The genetics company is closing a unit that was once seen as core to its future.

2 months ago · marketwatch.com

23andMe to slash 40% of its workforce, end therapeutics program to cut costs

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.

2 months ago · reuters.com

23andMe cuts 40% of its workforce

Genetic testing firm 23andMe said on Monday it is reducing its overall headcount by over 200 employees or about 40% of the workforce, as part of a restructuring program.

2 months ago · businessinsider.com

23andMe appoints new board members as it works to stem the company's slide

23andMe said it appointed three new independent directors to its board on Monday. All seven of 23andMe's previous directors resigned in September over its "strategic direction.

2 months ago · cnbc.com

23andMe appoints three new board members following abrupt resignations

23andMe appointed three new independent directors to its board, the company said Tuesday. The announcement comes about a month after all seven of 23andMe's previous independent directors abruptly resi...

2 months ago · cnbc.com

Inside the fall of 23andMe

Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what happened?

2 months ago · 247wallst.com

Avoid This Former High-Flying Stock Split Stock at All Costs

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon.